Automated image analysis system for studying cardiotoxicity in human pluripotent stem cell-Derived cardiomyocytes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Automated image analysis system for studying cardiotoxicity in human pluripotent stem cell-Derived cardiomyocytes ; volume:21 ; number:1 ; day:14 ; month:5 ; year:2020 ; pages:1-12 ; date:12.2020
BMC bioinformatics ; 21, Heft 1 (14.5.2020), 1-12, 12.2020
- Urheber
-
Cao, Lu
der Meer, Andries D. van
Verbeek, Fons J.
Passier, Robert
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12859-020-3466-1
- URN
-
urn:nbn:de:101:1-2020071806492719542384
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cao, Lu
- der Meer, Andries D. van
- Verbeek, Fons J.
- Passier, Robert
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Characterization of pluripotent stem cell-derived cardiomyocytes
Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)
Induced pluripotent stem cell-derived cardiomyocytes as model for studying CPVT caused by mutations in RYR2
Induced pluripotent stem cell-derived cardiomyocytes—more show than substance?
An integrated characterization of contractile, electrophysiological, and structural cardiotoxicity of Sophora tonkinensis Gapnep. in human pluripotent stem cell-derived cardiomyocytes
Investigating and Resolving Cardiotoxicity Induced by COVID‐19 Treatments using Human Pluripotent Stem Cell‐Derived Cardiomyocytes and Engineered Heart Tissues
Improving connexin 43 expression in induced pluripotent stem cell-derived cardiomyocytes
Electrophysiological characterization of embryonic and induced pluripotent stem cell-derived cardiomyocytes
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Characterization of pluripotent stem cell-derived cardiomyocytes
Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)
Induced pluripotent stem cell-derived cardiomyocytes as model for studying CPVT caused by mutations in RYR2
Induced pluripotent stem cell-derived cardiomyocytes—more show than substance?
An integrated characterization of contractile, electrophysiological, and structural cardiotoxicity of Sophora tonkinensis Gapnep. in human pluripotent stem cell-derived cardiomyocytes
Investigating and Resolving Cardiotoxicity Induced by COVID‐19 Treatments using Human Pluripotent Stem Cell‐Derived Cardiomyocytes and Engineered Heart Tissues
Improving connexin 43 expression in induced pluripotent stem cell-derived cardiomyocytes
Electrophysiological characterization of embryonic and induced pluripotent stem cell-derived cardiomyocytes
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Characterization of pluripotent stem cell-derived cardiomyocytes
Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)
Induced pluripotent stem cell-derived cardiomyocytes as model for studying CPVT caused by mutations in RYR2
Induced pluripotent stem cell-derived cardiomyocytes—more show than substance?
An integrated characterization of contractile, electrophysiological, and structural cardiotoxicity of Sophora tonkinensis Gapnep. in human pluripotent stem cell-derived cardiomyocytes
Investigating and Resolving Cardiotoxicity Induced by COVID‐19 Treatments using Human Pluripotent Stem Cell‐Derived Cardiomyocytes and Engineered Heart Tissues
Improving connexin 43 expression in induced pluripotent stem cell-derived cardiomyocytes
Electrophysiological characterization of embryonic and induced pluripotent stem cell-derived cardiomyocytes